Home
Home

pancreatic cancer

Halozyme rises on pancreatic cancer drug study

Halozyme rises on pancreatic cancer drug study
Yahoo/AP

Diabetes Drugs Are Being Evaluated for Pancreatic Risk

Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg

Peregrine's Epic Failure (Maybe)

Peregrine's Epic Failure (Maybe)
Motley Fool

3 Events Biotech Investors Need to Watch in 2013

3 Events Biotech Investors Need to Watch in 2013
Motley Fool

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug
TheStreet.com

Celgene’s Abraxane Benefits Pancreatic Cancer Patients

Celgene’s Abraxane Benefits Pancreatic Cancer Patients
Bloomberg

3 Things to Watch at Merrimack

3 Things to Watch at Merrimack
Motley Fool

Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?

Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?
Seeking Alpha

Abraxane Cancer Trials Help Justify Celgene Buyout

Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com

Is Threshold on the Threshold of Something Big?

Is Threshold on the Threshold of Something Big?
Motley Fool